◆ 会议时间：2025年5月2-6日
◆ 会议地点：奥地利 维也纳

◆ 会议简介：

2025年欧洲放射治疗与肿瘤学会(ESTRO)年会/大会将于2025年5月2-6日在奥地利维也纳举行，ESTRO年会是欧洲最大的放射肿瘤学会议与展览会。

欧洲放射治疗与肿瘤学学会(ESTRO)成立于1980年，是一个非营利性科学组织。ESTRO在欧洲内外拥有超过7600名成员，其中包括放射肿瘤学家、医学物理学家、放射生物学家和RTT（放射治疗师）以及肿瘤学界的其他相关专业人员。ESTRO致力于通过代表大会、特别会议、教育课程和出版物等，不断促进放射治疗学宣在多种肿瘤临床治疗中的应用，以改善对患者的护理。ESTRO通过组织放射肿瘤学和癌症多学科治疗各方面的会议使其在国际上享有盛誉，其中既有数千名代表参与的大型会议，亦有高度专业化的团体会议。同时，ESTRO也多次与其他国际知名学术组织合作，使会议成为一个能够充分交流知识和经验的平台。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

ESTRO 2025 - European SocieTy for Radiotherapy and Oncology (ESTRO) Congress

Date:
2-6 May 2025

Venue:
Messe Wien Exhibition & Congress Center
Vienna, Austria

摘要征文投稿：

Welcome letter

It is my great pleasure to invite you back to Vienna, Austria for ESTRO 2025 which will take place from 2 to 6 May. Building on the huge success of previous congresses in this vibrant city, situated ideally in the centre of Europe, we will convene the radiation oncology community for five days of learning, collaborating and connecting. 

The ambition of ESTRO to further reinforce radiation oncology as a key partner in multidisciplinary cancer care, and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, is expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’

Continuous evolution and refinement of radiation oncology is one important path of innovation to achieve this goal. ESTRO 2025 will put an emphasis on breakthrough research and innovation. Such revolutionary innovation is happening within our discipline, and even more opportunities open by collaboration and partnership with neighbouring and even distant fields of research. With this aim, the congress theme is Transformative Innovation Through Partnership. The programme will focus on how all stakeholders can learn from each other and cooperate to push the boundaries of radiation oncology and multidisciplinary cancer care in general. The theme will be reflected throughout the programme via state-of-the-art sessions.

The programme will emphasise interaction between audience and faculty, making top-level science accessible for all attending. Featuring panel discussions, pitch sessions and debates, the programme will connect the whole radiotherapy community. Leaders in the field will share their work and knowledge via symposia and teaching lectures. Joint sessions with partner associations will connect delegates with new communities and increase the reach of the ESTRO population. Nurturing those starting out in their careers remains a pillar of the society and therefore the Young Track will continue to provide educational activities focussed on those in the earlier stages of their careers. All sessions will promote collaboration between faculty and audience.

ESTRO strives to showcase the top-level scientific work being carried out by the radiation oncology community. With this in mind, the best abstract submitted to each track will be celebrated in a best proffered paper session. Other sessions will showcase the latest trial results. In addition to these highlight sessions, ESTRO will recognise the top-tier abstracts submitted to the congress. The highly popular mini-oral sessions will continue, enhancing the visibility of submitted research, while poster discussion sessions offer a platform to showcase work. We will continue to emphasise the interdisciplinarity of the ESTRO scientific programme by calling for abstracts which are of interest to a broad range of disciplines.

The main purpose of the ESTRO annual congress is to disseminate the latest science within the world of radiotherapy but also to reach out to the larger medical community and society in general. We will be increasing our communication of the breakthrough science via social channels and the press both during and after the congress. This will ensure engagement for those presenting at ESTRO 2025 far beyond the congress itself.

Networking with corporate partners is always invaluable. ESTRO 2025 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and to find out about the latest innovations in the field.

We look forward to welcoming you in Vienna.

With warm regards,

Matthias Guckenberger
ESTRO President
ESTRO 2025 Chair

ESTRO2025 注册费：

ESTRO members 2025 can benefit from a substantially reduced registration fee. To benefit from this member rate, please visit the membership page to become a member or renew your 2025 membership BEFORE proceeding with your order and discover the other membership advantages.

*ESTRO Members with specialty RTT may register at the In-training fee.

*To register as a student, you should be an ESTRO member and send a copy of your valid student card to events@estro.org before completing the registration. Institute letter is not accepted.

** Participants from emerging countries may register at a preferential rate. Emerging country fee applies to individuals from low-income and lower-middle-income economies as listed by the World Bank listing. You can check the list in here.

Group Registration

IMPORTANT reminder: Each participant must register using their individual email address, as they will each receive their unique login for the ESTRO 2025 apps.

Payment

The payment for web booking is processed securely through a credit card or direct debit card (normal bank card). If you'd like to pay with bank transfer, please send all your complete requests and details to events@estro.org.

Insurance 

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.

Cancellation and Refund

You may cancel your registration and get a full refund of the registration fee minus handling charges of 15%. This option is available until 1 month before the congress. Any cancellation request received within 1 month before the date of the congress will not be eligible for a refund. Please send an email with your request to events@estro.org.

◆ 参会对象：放射科医师，肿瘤科医师，护士，生物学家，物理学家，放疗技师，放射剂量师，药疗企业代表，以及其他相关卫生保健专业人士等等。